
Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting COVID-19 virus variants and relatives that threaten future coronavirus pandemics. The first volunteer is expected to receive the vaccine today at the NIHR Southampton Clinical Research Facility.
Read more:
https://www.cam.ac.uk/stories/DIOSCoVax_safetytrial?source=Snapzu
No comments:
Post a Comment